Novo Nordisk has announced that clinical trials for their investigational subcutaneous therapy concizumab will resume after an approximate five month pause, initiated in March 2020 in response to non-fatal thrombotic events in three enrolled…
Ferring Pharmaceuticals announced it was extending the recall of Stimate® (desmopressin) to the consumer/user level. Stimate is manufactured by Ferring Pharmaceuticals Inc. and is distributed and sold in the United States by CSL Behring. This marks…
CSL Behring and Ferring Pharmaceuticals have announced additional information about a recent recall of lots of Stimate® that was originally issued July 21, 2020.
Stimate® Nasal Spray is owned and manufactured by Ferring Pharmaceuticals Inc., and…
Individuals with inherited and acquired bleeding disorders, including hemophilia have substantial deficits in coagulation, for which they receive a variety of protein replacement products on a frequent basis. The coagulopathy intrinsic to COVID-19…
In 2019, the National Bleeding Disorders Foundation (formerly NHF) conducted a series of listening sessions and guided conversations with Black and African American members of the bleeding disorders community. The sessions were conducted in person…
Objectives:
This trial evaluated the hemostatic efficacy, pharmacokinetics, and safety of a recombinant VWF (rVWF) in adults with severe von Willebrand disease (VWD) (type 3 [VWF:Ag ≤ 3 IU/dL], severe type 1 [VWF:RCo< 20 IU/dL…
On July 21, 2020, Ferring Pharmaceuticals issued a voluntary recall of Stimate (desmopressin) nasal spray due to “superpotency” – in other words, amounts of desmopressin being higher than specified. Stimate is used to treat von Willebrand disease (…
The CDC is seeking input from people who live with pain, caregivers, and healthcare providers to gain a better understanding of their values and preferences related to pain and pain management. The project will complement CDC’s ongoing work to…
The National Hemophilia Foundation has created a new grant program to support local bleeding disorders organizations in their efforts to provide financial assistance and educational programs to people with bleeding disorders during the coronavirus…
Scott Miller, chair of the board of directors of the National Hemophilia Foundation (NHF) made a pledge to diversify the board of directors of the organization during NHF’s Bleeding Disorders Conference on August 1, 2020. During his speech at NHF’s…